M6PR Targeting Chimera (Avilar Therapeutics)

N/A

Report date: 2026/04/22 14:15:42

Base Information

Drug NameM6PR Targeting Chimera (Avilar Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Lysosome-Targeting Chimaeras (LYTAC)
Mechanisms of ActionInsulin-like growth factor II receptor degraders
TargetsInsulin-like growth factor II receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvilar Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAvilar Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A